TcrossGlobal

CTO-PCI in Patients in Stable Angina: The ORBITA-CTO Trial

The ORBITA-CTO trial demonstrated that among selected patients with a single-vessel coronary CTO and documented ischemia and myocardial viability, PCI for CTO improved angina symptoms compared with a placebo procedure, according to a study presented by Dr. Sarosh Khan, Mid and South Essex NHS Foundation Trust, United Kingdom, in the Late-Breaking Clinical Trials session at ACC.26.

Fifty symptomatic patients with stable angina who had a single-vessel CTO with a J-CTO score ≤3,...

Continue reading this article

Select an option below:

Free Registration
Already have an account?
Log In

Introducing the main contents

Conference Reports

Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!

Complex PCI Cases

Features case reports on patients with complex lesions encountered in daily clinical practice.

Live Demonstration CoursesComing soon

In this section you will find live videos of catheter interventions for complex lesions.

What is TCROSS NEWS GLOBAL?

TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.

Learn more about TCROSS NEWS Global

This website is automatically translated using Google Translate.